SB230
Authorize pharmacists to test, treat certain health conditions
Summary
This bill authorizes pharmacists in Ohio to screen, test, and provide treatment for certain respiratory health conditions, including influenza, COVID-19, and others as specified by the state board of pharmacy. It mandates that health insurance providers reimburse pharmacists for these services under certain conditions. The bill also allows pharmacists to delegate certain tasks to pharmacy interns and technicians under supervision.
Rationale
The bill expands the role of pharmacists in healthcare, which aligns with the Libertarian emphasis on individual choice and market solutions in healthcare. However, it also involves government regulation and mandates for reimbursement, which may conflict with the principles of minimal government intervention espoused by both the LP and LPO.
Risks and Concerns
- Potential for increased government control over healthcare practices
- Risk of overregulation impacting pharmacist autonomy
- Concerns about the quality of care provided by non-physicians